Community Update – Capsida Clinical Trial

Dear STXBP1 Community, 

We are sharing a new letter from Capsida with an update on the CAP-002 SYNRGY clinical trial.

As always, the STXBP1 Foundation remains committed to transparency and to sharing accurate, verified information with our community. We continue to stay in contact with Capsida, the study sponsor, and investigators, and we will share additional updates as they become available.

We know this remains an important and sensitive topic for many families, and we are grateful to the community for your continued patience and care.

Regards, 

The STXBP1 Foundation Team

Below is the updated letter to the STXBP1 Community from Capsida


Next
Next

Chords for Callum: Jon Stickley to lead powerhouse fundraising concert